Swedbank AB trimmed its position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 25.5% during the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,310,047 shares of the healthcare conglomerate's stock after selling 447,760 shares during the period. Swedbank AB owned approximately 0.14% of UnitedHealth Group worth $408,695,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. Vanguard Group Inc. grew its position in UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate's stock valued at $47,519,620,000 after acquiring an additional 5,583,343 shares during the last quarter. Wellington Management Group LLP grew its position in UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate's stock valued at $13,537,859,000 after acquiring an additional 2,486,839 shares during the last quarter. GAMMA Investing LLC grew its position in UnitedHealth Group by 56,142.1% in the 1st quarter. GAMMA Investing LLC now owns 8,295,153 shares of the healthcare conglomerate's stock valued at $4,344,586,000 after acquiring an additional 8,280,404 shares during the last quarter. Bank of New York Mellon Corp grew its position in UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate's stock valued at $4,257,131,000 after acquiring an additional 196,696 shares during the last quarter. Finally, Nuveen LLC bought a new position in shares of UnitedHealth Group during the 1st quarter worth $3,846,764,000. Hedge funds and other institutional investors own 87.86% of the company's stock.
UnitedHealth Group Price Performance
Shares of NYSE:UNH traded up $1.90 during trading on Friday, reaching $336.72. The stock had a trading volume of 13,528,738 shares, compared to its average volume of 13,032,599. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The stock has a market cap of $304.96 billion, a PE ratio of 14.59, a PEG ratio of 2.23 and a beta of 0.45. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The business has a fifty day moving average price of $295.01 and a 200-day moving average price of $366.14.
UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts' consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts' expectations of $111.75 billion. During the same quarter in the prior year, the firm earned $6.80 EPS. UnitedHealth Group's revenue for the quarter was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. The ex-dividend date is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. UnitedHealth Group's dividend payout ratio is presently 38.30%.
Analyst Upgrades and Downgrades
A number of equities research analysts recently weighed in on the company. Royal Bank Of Canada decreased their price objective on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating for the company in a research note on Wednesday, July 30th. Morgan Stanley upped their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the stock an "overweight" rating in a research note on Friday, September 12th. Truist Financial upped their price objective on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research note on Tuesday, September 9th. Bank of America increased their price target on UnitedHealth Group from $290.00 to $325.00 and gave the company a "neutral" rating in a research note on Monday, August 18th. Finally, KeyCorp decreased their price target on UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Sixteen equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, UnitedHealth Group has a consensus rating of "Moderate Buy" and an average target price of $358.95.
Read Our Latest Stock Report on UNH
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Stories

Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.